Hepatitis C virus in elderly cancer patients

European Journal of Internal Medicine

Volumn 17, Issue 5, 2006, Pages 325-329

  Malaguarnera, Mariano ^a   Gargante, Maria Pia ^a   Risino, Corrado ^a   Ranno, Salvatore ^a   Berretta, Massimiliano ^a   Cannizzaro, Matteo Angelo ^a   Costanzo, Mario ^a   Fricia, Tiziana ^b   Rampello, Elvira ^b   Romano, Marcello ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b GARIBALDI HOSPITAL   (Italy)

Author keywords

Cancer; Elderly; HCV prevalence; Hepatitis C virus; Immunity; Tumors

Indexed keywords

AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CLINICAL FEATURE; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; EVALUATION; FEMALE; GERIATRIC PATIENT; HEPATITIS C VIRUS; HUMAN; INFECTION RATE; KIDNEY CANCER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; NONHODGKIN LYMPHOMA; PANCREAS CANCER; PROSTATE CANCER; STATISTICAL SIGNIFICANCE; THYROID CANCER; UTERINE CERVIX CANCER; VAGINA CANCER; VIRUS CARCINOGENESIS; VIRUS DETECTION;

EID: 33746069304     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2006.02.004     Document Type: Article

References (32)

1. Pagano J.S., Blaser M., Buendia M.A., Damania B., Khalili K., Raab-Traub N., et al. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 14 (2004) 453-471
2. Sun C.A., Wu D.M., Lin C.C., Lu S.N., You S.L., Wang L.Y., et al. Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. Am J Epidemiol 157 (2003) 674-682
3. Liang T.J., Rehermann B., Seeff L.B., and Hoofnagle J.H. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 132 (2000) 296-305
4. Sung V.M., Shimodaira S., Doughty A.L., Picchio G.R., Can H., Yen T.S., et al. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 77 (2003) 2134-2146
5. Zignego A.L., De Carli M., Monti M., Carecci G., La Villa G., Giannini C., et al. Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. J Med Virol 47 (1995) 58-64
6. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., and Petracca R. Binding of hepatitis C virus to CD81. Science 282 (1998) 938-941
7. Silvestri F., Pipan C., Barillari G., Zaja F., Fanin R., Infanti L., et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 87 (1996) 4296-4301
8. Kitay-Cohen Y., Amiel A., Hilzenrat N., Buskila D., Ashur Y., Fejgin M., et al. Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood 96 (2000) 2910-2912
9. Sugiyama K., Kato N., Ikeda M., Mizutani T., Shimotohno K., Kato T., et al. Hepatitis C virus in pelvic lymphonodes and female reproductive organs. Jpn J Cancer Res 88 (1997) 925-927
10. Sata M., Noguchi S., Ide T., Suzuki H., Kumashiro R., Nagao Y., et al. Lack of detection of hepatitis C virus replicative intermediate in abdominal lymphonodes. Hepatol Res 10 (1998) 66-73
11. Wang J.T., Sheu J.C., Lin J.T., Wang T.H., and Chen D.S. Detection of replication form of hepatitis C virus RNA in peripheral blood mononuclear cell. J Infect Dis 166 (1992) 1167-1169
12. Sherker A.H., Twu J.S., Reyes G.R., and Robinson W.S. Presence of viral replicative intermediates in the liver and serum of patients infected with chronic hepatitis C virus. J Med Virol 39 (1993) 91-96
13. Taliani G., Celestino D., Badolato M.C., Pennica A., Bozza A., Poliandri G., et al. Hepatitis C virus infection of salivary grand hepithelial cells. Lack of evidence. J Hepatol 26 (1997) 1200-1206
14. Nagao Y., Sata M., Tanikawa K., Itoh K., and Kameyama T. High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer. J Oral Pathol Med 24 (1995) 354-360
15. Nagao Y., Sata M., Itoh K., Chiba I., Komiyama K., Yanoma S., et al. High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma. Hepatol Res 7 (1997) 206-211
16. Becker-Andre M., and Hahlbrock K. Absolute mRNA quantification using the polymerase chain reaction (PCR): a novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res 17 (1989) 9437-9446
17. Simmonds P., Bukh J., Combet C., Deleage G., Enomoto N., Feinstone S., et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42 (2005) 962-973
18. Simmonds P., Holmes E.C., Cha T.A., Chan S.W., McOmish F., Irvine B., et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74 (1993) 2391-2399
19. Topeli A., Ozyilkan O., Ozyilkan E., Kars A., and Firat D. Prevalence of hepatitis C, B and D markers in cancer patients in Turkey. Eur J Clin Microbiol Infect Dis 13 (1994) 38-40
20. Ferri C., La Civita L., Zignego A.L., and Pasero G. Viruses and cancers: possible role of hepatitis C virus. Eur J Clin Invest 27 (1997) 711-718
21. Huang H., Fujii H., Sankila A., Mahler-Araujo B.M., Matsuda M., Cathomas G., et al. Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol 155 (1999) 1795-1801
22. Machida K., Cheng K.T., Sung V.M., Shimodaira S., Lindsay K.L., Levine A.M., et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci U S A 101 (2004) 4262-4267
23. Petersen-Mahrt S.K., Harris R.S., and Neuberger M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418 (2002) 99-103
24. Malaguarnera M., Pistone G., Neri S., Romano M., Brogna A., and Musumeci S. Interleukin-2 plus ribavirin versus interferon-alpha-2b plus ribavirin in patients with chronic hepatitis C who did not respond to previous interferon-alpha-2b treatment. BioDrugs 18 (2004) 407-413
25. Malaguarnera M., Guccione N., Musumeci S., Brogna A., Motta M., and Di Fazio I. Intravenous immunoglobulin plus interferon-alpha in autoimmune hepatitis C. BioDrugs 18 (2004) 63-70
26. Battegay M. Immunity to hepatitis C virus: a further piece of the puzzle. Hepatology 24 (1996) 961-963
27. Malaguarnera L., Ferlito L., Di Mauro S., Imbesi R.M., Scalia G., and Malaguarnera M. Immunosenescence and cancer: a review. Arch Gerontol Geriatr 32 (2001) 77-93
28. Moriya K., Fujie H., Shintani Y., Yotsuyanagi H., Tsutsumi T., Ishibashi K., et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4 (1998) 1065-1067
29. Ferri C., La Civita L., Monti M., Longobardo G., Greco F., Pasero G., et al. Can type C hepatitis infection be complicated by malignant lymphoma?. Lancet 346 (1995) 1426-1427
30. Cacoub P., Lunel F., Musset L., Frangeul L., Cresta P., Perrin M., et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106 (1994) 1291-1300
31. Cacoub P., Fabiani F.L., Musset L., Perrin M., Frangeul L., Leger J.M., et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 96 (1994) 124-132
32. Neri S., Ierna D., Mauceri B., Abate G., Cilio D., Bordonaro F., et al. Can ultrasonographic findings of perihepatic lymphadenopathy promote investigations to detect possible presence of virus C infection in non-symptomatic subjects?. Hepatol Res 27 (2003) 124-128